# KRYSTAL- KetopRofen lYsinate Sore ThroAt Lozenges

> **NCT00929877** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 801 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** KETOPROFEN(RP19583)
- **DRUG:** KETOPROFEN(RP19583)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00929877
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 801 (ACTUAL)
- **Last updated:** 2010-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929877, "KRYSTAL- KetopRofen lYsinate Sore ThroAt Lozenges". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00929877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*